Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection

NCT04447235 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

77

Enrollment

OTHER

Sponsor class

Stopped futility analysis has demonstrated no difference between arms

Conditions

Cancer
COVID
Coronavirus Infection

Interventions

DRUG: Placebo
DRUG: Ivermectin
DRUG: Losartan

Sponsor

Instituto do Cancer do Estado de São Paulo